SCHEMBL6425818

SCHEMBL6425818

N#CC1(C(=O)Nc2cc3c(/C=C/c4ccc(F)cc4)n[nH]c3cc2F)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.42
AURKA O14965 6/20 0.41
AURKB Q96GD4 5/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
TTK P33981 2/20 0.36
CHEK1 O14757 3/20 0.36
FGFR1 P11362 4/20 0.35
NTRK1 P04629 2/20 0.35
BMPR1B O00238 1/20 0.35
PLK4 O00444 1/20 0.35
STK25 O00506 1/20 0.35
CIT O14578 1/20 0.35
RIOK3 O14730 1/20 0.35
IKBKB O14920 1/20 0.35
GAK O14976 1/20 0.35
DCLK1 O15075 1/20 0.35
CHUK O15111 1/20 0.35
MUSK O15146 1/20 0.35
EPHB6 O15197 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426047 0.87 KDR (0.45) KDRAURKAAURKBTTKCHEK1
SCHEMBL6425975 0.86 AURKA (0.46) KDRAURKAAURKBTTKCHEK1
SCHEMBL6428457 0.86 KDR (0.46) KDRAURKAAURKBTTKCHEK1
SCHEMBL6427399 0.86 AURKA (0.43) KDRAURKAAURKBTTKCHEK1
SCHEMBL6427742 0.85 KDR (0.44) KDRAURKAAURKBTTKCHEK1
SCHEMBL6426485 0.84 AURKA (0.43) KDRAURKAAURKBTTKCHEK1
SCHEMBL6428603 0.84 KDR (0.44) KDRAURKAAURKBCHEK1FGFR1
SCHEMBL5034271 0.84 AURKA (0.43) KDRAURKAAURKBTTKCHEK1
SCHEMBL5030054 0.83 AURKA (0.44) KDRAURKAAURKBTTKCHEK1
SCHEMBL4150362 0.82 AURKA (0.49) KDRAURKAAURKBTTKCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261339-A1 Pyrazole compound and medicinal composition containing the same CNKSR1, NR3C2, CSNK2B KDR 1044/4885AURKA 710/4885AURKB 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.